| 摘要 |
Compounds of the formula I <IMAGE> in which the individual substituents have the meanings stated in the claim, are prepared. The process is based on replacement of an -SR9 group in which R9 denotes lower alkyl by the -NR2R3 group. The resulting products of the formula I and their acid addition salts have antihypertensive properties and properties increasing venous tone. |
